NCT07624058

Brief Summary

direct comparisons between ESPB and M-TAPA for postoperative analgesia after LC remain limited. This is an important area of clinical interest because the two blocks differ significantly in their anatomical targets, mechanism of analgesia, and likely dermatomal coverage. The ESPB provides analgesia through paravertebral spread affecting both dorsal and ventral rami, thereby offering posterior and visceral pain relief, whereas M-TAPA directly targets the thoracoabdominal nerves, resulting in better anterior and lateral abdominal wall analgesia. Understanding which technique offers superior or more balanced analgesia could help to optimise regional anaesthesia strategies in LC and to improve patient outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Apr 2026Mar 2027

Study Start

First participant enrolled

April 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 29, 2026

Last Update Submit

May 29, 2026

Conditions

Keywords

pain controlerector spinae block

Outcome Measures

Primary Outcomes (1)

  • Time to First Analgesic request

    minutes

    postoperative day 1

Secondary Outcomes (4)

  • Total Nalbuphine consumption

    postoperative day 1

  • Visual analogue score

    postoperative day1

  • Quality of postoperative recovery

    postoperative day 1

  • Incidence of complications or adverse events

    postoperative day 5

Study Arms (2)

group 1

ACTIVE COMPARATOR

patients will receive bilateral ESP block

Other: bilateral ESP block

group 2

EXPERIMENTAL

patients will receive bilateral M-TAPA block

Other: bilateral M-TAPA block

Interventions

bilateral ESP block with injection of 20 ml 0.25% bupivacaine.

group 1

bilateral M-TAPA block with injection of 20 ml of 0.25% bupivacaine.

group 2

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: between 30 - 65
  • American Society of Anaesthesiologists physical status: I- III
  • Body mass index: 18-35 kg.m-2

You may not qualify if:

  • Patient Refusal
  • Allergy to local anaesthetic agents.
  • Skin infection at the site of injection.
  • Coagulopathy.
  • Diabetes Mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University

Alexandria, Egypt

RECRUITING

Related Publications (1)

  • Tulgar S, Selvi O, Thomas DT, Deveci U, Ozer Z. Modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) provides effective analgesia in abdominal surgery and is a choice for opioid sparing anesthesia. J Clin Anesth. 2019 Aug;55:109. doi: 10.1016/j.jclinane.2019.01.003. Epub 2019 Jan 9. No abstract available.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • sarah m elgamal, MD

    Alexandria University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

sarah m elgamal, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

May 29, 2026

First Posted

June 3, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations